(Q39526281)

English

Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer

scientific article published on 12 June 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

peritoneal carcinomatosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Isabelle Navarro-Teulon

6

object named as

Isabelle Teulon

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Pierre-Emmanuel Colombo

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mahfoud Boustta

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sylvain Poujol

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Marta Jarlier

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Françoise Bressolle

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Maha-Zohra Ladjemi

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Frederic Pinguet

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Philippe Rouanet

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Michel Vert

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

12 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

122

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

632-640

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Cancer of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Intraperitoneal antineoplastic drug delivery: rationale and results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Antitumor effect of cisplatin incorporated into polylactic acid microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Polymeric anticancer drugs with pH-controlled activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Metabolite-derived artificial polymers designed for drug targeting, cell penetration and bioresorption

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Antitumor activity and toxicological properties of doxorubicin conjugated to [alpha],[beta]-poly[(2-hydroxyethyl)-L-aspartamide] administered intraperitoneally in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Alkylated poly(L-lysine citramide) as models to investigate the ability of amphiphilic macromolecular drug carriers to physically entrap lipophilic compounds in aqueous media

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

HPLC methods for the determination of bound and free doxorubicin, and of bound and free galactosamine, in methacrylamide polymer-drug conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

A sensitive procedure for the quantitation of free and N-(2-hydroxypropyl) methacrylamide polymer-bound doxorubicin (PK1) and some of its metabolites, 13-dihydrodoxorubicin, 13-dihydrodoxorubicinone and doxorubicinone, in human plasma and urine by r

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

In vivo bioluminescence imaging to evaluate estrogenic activities of endocrine disrupters

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Random-effects models for longitudinal data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

[Secondary debulking surgery and intraperitoneal chemotherapy in advanced or recurrent epithelial ovarian cancer]

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Pharmacokinetics of intraperitoneal cisplatin and doxorubicin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Generation of a syngeneic mouse model to study the intraperitoneal dissemination of ovarian cancer with in vivo luciferase imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.05.032

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.05.032

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39526281&oldid=1984638743"